{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:21:12Z","timestamp":1775247672242,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bbr.2014.04.033","type":"journal-article","created":{"date-parts":[[2014,4,27]],"date-time":"2014-04-27T04:46:17Z","timestamp":1398573977000},"page":"204-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The murine serotonin syndrome \u2013 Evaluation of responses to 5-HT-enhancing drugs in NMRI mice"],"prefix":"10.1016","volume":"277","author":[{"given":"Robert","family":"Haberzettl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Bert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2014.04.033_bib0005","first-page":"1439","article-title":"Serotonin syndrome: a brief review","volume":"168","author":"Birmes","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.bbr.2014.04.033_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1526-4637.2003.03005.x","article-title":"Serotonin syndrome and other serotonergic disorders","volume":"4","author":"Ener","year":"2003","journal-title":"Pain Med"},{"key":"10.1016\/j.bbr.2014.04.033_bib0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2013.08.045","article-title":"Animal models of the serotonin syndrome: a systematic review","volume":"256C","author":"Haberzettl","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.04.033_bib0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neuint.2007.08.015","article-title":"Perspectives on genetic animal models of serotonin toxicity","volume":"52","author":"Kalueff","year":"2008","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2014.04.033_bib0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0024-3205(79)90155-3","article-title":"Behavioral and biochemical actions of p-chlorophenylethylamine (p-CPEA) in mice","volume":"24","author":"Hwang","year":"1979","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2014.04.033_bib0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0169-328X(03)00205-5","article-title":"A genetic screen for mouse mutations with defects in serotonin responsiveness","volume":"115","author":"Weiss","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bbr.2014.04.033_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.neuropharm.2011.01.025","article-title":"Implication of 5-HT(2B) receptors in the serotonin syndrome","volume":"61","author":"Diaz","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2014.04.033_bib0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2005.09.020","article-title":"Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT","volume":"167","author":"Bert","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.04.033_bib0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0091-3057(96)00472-8","article-title":"An ethopharmacological analysis of selective activation of 5-HT1A receptors: the mouse 5-HT1A syndrome","volume":"57","author":"Blanchard","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.04.033_bib0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","article-title":"Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice","volume":"53","author":"Fox","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2014.04.033_bib0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(88)90205-1","article-title":"The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice","volume":"154","author":"Yamada","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1601-183X.2006.00270.x","article-title":"Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice","volume":"6","author":"Kalueff","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.bbr.2014.04.033_bib0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bbr.2014.04.033_bib0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1517\/14740338.7.5.587","article-title":"Drug-induced serotonin syndrome: a review","volume":"7","author":"Sun-Edelstein","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bbr.2014.04.033_bib0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bjp.2008.243","article-title":"Prediction of clinical response based on pharmacokinetic\/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice","volume":"155","author":"Kreilgaard","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.1971.tb12034.x","article-title":"Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and l-tryptophan","volume":"18","author":"Grahame-Smith","year":"1971","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2014.04.033_bib0085","unstructured":"America T. Material Safety Data Sheet \u2013 5-Hydroxy-dl-tryptophan; 2011."},{"key":"10.1016\/j.bbr.2014.04.033_bib0090","unstructured":"America T. Material Safety Data Sheet \u2013 Fluoxetine Hydrochloride; 2011."},{"key":"10.1016\/j.bbr.2014.04.033_bib0095","unstructured":"Drugfuture. Chemical Toxicity Database; 2014."},{"key":"10.1016\/j.bbr.2014.04.033_bib0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2005.05.028","article-title":"Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret","volume":"516","author":"Lau","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pbb.2008.06.023","article-title":"Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia","volume":"91","author":"Maehara","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.04.033_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.wnf.0000177642.89888.85","article-title":"The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment","volume":"28","author":"Isbister","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1476-5381.1978.tb17290.x","article-title":"The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and l-tryptophan or tranylcypromine and l-DOPA to rats","volume":"64","author":"Deakin","year":"1978","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.1990.tb14651.x","article-title":"The effects of Ca-2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice","volume":"99","author":"Green","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pnpbp.2004.01.013","article-title":"Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine","volume":"28","author":"Shioda","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.04.033_bib0130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1472-8206.1998.tb00976.x","article-title":"Serotonin syndrome: history and risk","volume":"12","author":"Gillman","year":"1998","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-008-1268-7","article-title":"Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice","volume":"201","author":"Fox","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.04.033_bib0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(87)90289-5","article-title":"Pharmacological analysis of the variation in behavioural responses to tryptamine in five strains of mice","volume":"140","author":"Yamada","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0145","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1460-9568.2008.06201.x","article-title":"Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat","volume":"27","author":"Nakatani","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2014.04.033_bib0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(90)90593-Z","article-title":"Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data","volume":"515","author":"Stamford","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2014.04.033_bib0155","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","article-title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors","volume":"36","author":"Darmani","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.04.033_bib0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0028-3908(74)90045-8","article-title":"Effect of indolealkylamine manipulations on locomotor activity in rats","volume":"13","author":"Jacobs","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2014.04.033_bib0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3565(25)21483-5","article-title":"Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat","volume":"228","author":"Lucki","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2014.04.033_bib0170","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.7221567","article-title":"Two distinct central serotonin receptors with different physiological functions","volume":"212","author":"Peroutka","year":"1981","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bbr.2014.04.033_bib0175","first-page":"G419","article-title":"5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice","volume":"292","author":"Wang","year":"2007","journal-title":"Am J Physiol-Gastr L"},{"key":"10.1016\/j.bbr.2014.04.033_bib0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00008877-200207000-00008","article-title":"Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats","volume":"13","author":"Van Oekelen","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-001-0986-x","article-title":"Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex","volume":"160","author":"Bymaster","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.04.033_bib0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00510258","article-title":"The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats","volume":"311","author":"Ortmann","year":"1980","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0195","series-title":"Levine's pharmacology \u2013 drug actions and reactions","article-title":"11. Factors modifying the effects of drugs in individuals","author":"Walsh","year":"2005"},{"key":"10.1016\/j.bbr.2014.04.033_bib0200","series-title":"Introduction to pharmacology","article-title":"Drug interactions","author":"Hollinger","year":"2008"},{"key":"10.1016\/j.bbr.2014.04.033_bib0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.2042-7158.1993.tb07105.x","article-title":"Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus l-5-hydroxytryptophan","volume":"45","author":"Perry","year":"1993","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.2042-7158.1996.tb03982.x","article-title":"On the in-vivo modulation of neostriatal dopamine release by fluoxetine and 5-hydroxy-l-tryptophan in conscious rats","volume":"48","author":"Li","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0215","first-page":"309","article-title":"The serotonin syndrome","volume":"62","author":"Bijl","year":"2004","journal-title":"Netherlands J Med"},{"key":"10.1016\/j.bbr.2014.04.033_bib0220","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.04.033_bib0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1440-1681.1988.tb01012.x","article-title":"A study of central neurotransmitter mechanisms in morphine-induced \u2018Straub reaction\u2019 in mice: role of central dopamine receptors","volume":"15","author":"Gupta","year":"1988","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bbr.2014.04.033_bib0230","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1523\/JNEUROSCI.23-07-02582.2003","article-title":"Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors","volume":"23","author":"Fonck","year":"2003","journal-title":"J Neurosci"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814002514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814002514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:05:31Z","timestamp":1759064731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432814002514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":46,"alternative-id":["S0166432814002514"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2014.04.033","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The murine serotonin syndrome \u2013 Evaluation of responses to 5-HT-enhancing drugs in NMRI mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2014.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}